✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Exelixis Inc

Common Name
Exelixis
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
1,077
Ticker
EXEL
Exchange
NASDAQ/NGS
Description
Exelixis Inc. is an oncology-focused biotechnology company dedicated to the discovery, development, and commercialization of new medicines for difficult-to-treat cancers. Its lead product, CABOMETYX t...

Exelixis's Board Composition Data

Explore Exelixis's board composition data, including the total number of board members and their breakdown by executive/non-executive status, independence, and gender.

Metric2026-05-26
Total Board Member Count
11a
Executive Board Member Count
1a
Non-executive Board Member Count
10a
Independent Board Member Count
10a
Non-independent Board Member Count
1a
Female Board Member Count
4a
Male Board Member Count
7a
Non-binary Board Member Count
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Exelixis’s Board Composition Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Exelixis's DEF 14A 2025